Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis.

Kuo, Joseph; Serrano, Sonia Simón; Grönberg, Alvar; Massoumi, Ramin; Hansson, Magnus Joakim; Gallay, Philippe.

Afiliação

Kuo J; Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Serrano SS; NeuroVive Pharmaceutical AB, Lund, Sweden.
Grönberg A; Department of Laboratory Medicine, Translational Cancer Research, Lund University, Lund, Sweden.
Massoumi R; NeuroVive Pharmaceutical AB, Lund, Sweden.
Hansson MJ; Department of Laboratory Medicine, Translational Cancer Research, Lund University, Lund, Sweden.
Gallay P; NeuroVive Pharmaceutical AB, Lund, Sweden.

Front Pharmacol ; 10: 1129, 2019.

Article em En | MEDLINE | ID: mdl-31611801